Korro Bio (KRRO) Prepaid Assets (2018 - 2026)
Korro Bio's (KRRO) quarterly Prepaid Assets came in at $6.2 million in Q1 2026, up 42.11% YoY from $4.4 million in Q1 2025, and down 0.86% on a QoQ basis from $6.2 million in Q4 2025.
Korro Bio (KRRO) Prepaid Assets (2018 - 2026) Analysis & Trends
Korro Bio (KRRO) has 9 years of Prepaid Assets data on file, last reported at $6.2 million in Q1 2026.
- Quarterly Prepaid Assets rose 42.11% year-over-year to $6.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.2 million (up 42.11% YoY) and the FY2025 annual result came in at $6.2 million, up 66.99% from the prior year.
- Prepaid Assets eased to $6.2 million in Q1 2026, from $6.2 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $6.2 million in Q4 2025 to a low of $423000.0 in Q3 2023.
- A 5-year average of $3.4 million and a median of $3.3 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets plunged 74.25% — and 2024, when it jumped 849.88%.
- Tracing KRRO's Prepaid Assets over 5 years: stood at $1.2 million in 2022, then soared by 144.72% to $3.0 million in 2023, then increased by 24.08% to $3.7 million in 2024, then soared by 66.99% to $6.2 million in 2025, then fell by 0.86% to $6.2 million in 2026.
- The last three Prepaid Assets figures came in at $6.2 million (Q1 2026), $6.2 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Korro Bio | 231.77 Mn | 116.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.60 Mn |
| Mar 31, 2026 | 6.19 Mn |
| Dec 31, 2025 | 6.25 Mn |
| Sep 30, 2025 | 4.93 Mn |
| Jun 30, 2025 | 5.18 Mn |
| Mar 31, 2025 | 4.36 Mn |
| Dec 31, 2024 | 3.74 Mn |
| Sep 30, 2024 | 4.02 Mn |
| Jun 30, 2024 | 4.43 Mn |
| Mar 31, 2024 | 3.31 Mn |
| Dec 31, 2023 | 3.02 Mn |
| Sep 30, 2023 | 423,000.00 |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | 2.64 Mn |
| Dec 31, 2022 | 1.23 Mn |
| Sep 30, 2022 | 1.64 Mn |
| Jun 30, 2022 | 2.41 Mn |
| Mar 31, 2022 | 2.58 Mn |
| Dec 31, 2021 | 2.38 Mn |
| Sep 30, 2021 | 1.84 Mn |